Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in Austria

被引:1
作者
Secco, Katharina [1 ]
Baumann, Petra Martina [1 ]
Poettler, Tina [1 ]
Aberer, Felix [1 ]
Cigler, Monika [1 ]
Elsayed, Hesham [1 ]
Harer, Clemens Martin [1 ]
Weitgasser, Raimund [2 ]
Schuetz-Fuhrmann, Ingrid [3 ,4 ]
Mader, Julia Katharina [1 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Auenbruggerpl 15, A-8036 Graz, Austria
[2] Private Clin Wehrle Diakonissen, Dept Internal Med & Diabetol, A-5026 Salzburg, Austria
[3] Hosp Hietzing, Med Div Metab Dis & Nephrol 3, A-1130 Vienna, Austria
[4] Karl Landsteiner Inst, Inst Metab Dis & Nephrol, A-1130 Vienna, Austria
关键词
COVID-19; glycemic control; isCGM; lockdown; pandemic; type; 1; diabetes; CORONAVIRUS DISEASE 2019; IMPACT;
D O I
10.3390/s24144514
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Objective: The aim of this analysis was to assess glycemic control before and during the coronavirus disease (COVID-19) pandemic. Methods: Data from 64 (main analysis) and 80 (sensitivity analysis) people with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM) were investigated retrospectively. The baseline characteristics were collected from electronic medical records. The data were examined over three periods of three months each: from 16th of March 2019 until 16th of June 2019 (pre-pandemic), from 1st of December 2019 until 29th of February 2020 (pre-lockdown) and from 16th of March 2020 until 16th of June 2020 (lockdown 2020), representing the very beginning of the COVID-19 pandemic and the first Austrian-wide lockdown. Results: For the main analysis, 64 individuals with T1D (22 female, 42 male), who had a mean glycated hemoglobin (HbA1c) of 58.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration 13.5 years (5.5 to 22.0 years) were included in the analysis. The time in range (TIR[70-180mg/dL]) was the highest percentage of measures within all three studied phases, but the lockdown 2020 phase delivered the best data in all these cases. Concerning the time below range (TBR[<70mg/dL]) and the time above range (TAR[>180mg/dL]), the lockdown 2020 phase also had the best values. Regarding the sensitivity analysis, 80 individuals with T1D (26 female, 54 male), who had a mean HbA1c of 57.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration of 12.5 years (5.5 to 20.7 years), were included. The TIR[70-180mg/dL] was also the highest percentage of measures within all three studied phases, with the lockdown 2020 phase also delivering the best data in all these cases. The TBR[<70mg/dL] and the TAR[>180mg/dL] underscored the data in the main analysis. Conclusion: Superior glycemic control, based on all parameters analyzed, was achieved during the first Austrian-wide lockdown compared to prior periods, which might be a result of reduced daily exertion or more time spent focusing on glycemic management.
引用
收藏
页数:16
相关论文
共 36 条
  • [11] FreeStyle Libre, FreeStyle Abbott
  • [12] Introducing Telemedicine in Italy: Citizens' Awareness of a New Healthcare Resource
    Galle, Francesca
    Oliva, Stefania
    Covelli, Edoardo
    Del Casale, Antonio
    Da Molin, Giovanna
    Liguori, Giorgio
    Orsi, Giovanni Battista
    Napoli, Christian
    [J]. HEALTHCARE, 2023, 11 (15)
  • [13] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) : 1757 - 1766
  • [14] Impact of sex and gender on COVID-19 outcomes in Europe
    Gebhard, Catherine
    Regitz-Zagrosek, Vera
    Neuhauser, Hannelore K.
    Morgan, Rosemary
    Klein, Sabra L.
    [J]. BIOLOGY OF SEX DIFFERENCES, 2020, 11 (01)
  • [15] Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study
    Ghesquiere, L.
    Garabedian, C.
    Drumez, E.
    Lemaitre, M.
    Cazaubiel, M.
    Bengler, C.
    Vambergue, A.
    [J]. DIABETES & METABOLISM, 2021, 47 (02)
  • [16] A Narrative Review of the Launch and the Deployment of Telemedicine in Italy during the COVID-19 Pandemic
    Giansanti, Daniele
    Morone, Giovanni
    Loreti, Alice
    Germanotta, Marco
    Aprile, Irene
    [J]. HEALTHCARE, 2022, 10 (03)
  • [17] Clinical Characteristics of Coronavirus Disease 2019 in China
    Guan, W.
    Ni, Z.
    Hu, Yu
    Liang, W.
    Ou, C.
    He, J.
    Liu, L.
    Shan, H.
    Lei, C.
    Hui, D. S. C.
    Du, B.
    Li, L.
    Zeng, G.
    Yuen, K. -Y.
    Chen, R.
    Tang, C.
    Wang, T.
    Chen, P.
    Xiang, J.
    Li, S.
    Wang, Jin-lin
    Liang, Z.
    Peng, Y.
    Wei, L.
    Liu, Y.
    Hu, Ya-hua
    Peng, P.
    Wang, Jian-ming
    Liu, J.
    Chen, Z.
    Li, G.
    Zheng, Z.
    Qiu, S.
    Luo, J.
    Ye, C.
    Zhu, S.
    Zhong, N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) : 1708 - 1720
  • [18] Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)
    Harreiter, Juergen
    Roden, Michael
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 1) : 7 - 17
  • [19] The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Holt, Richard I. G.
    DeVries, J. Hans
    Hess-Fischl, Amy
    Hirsch, Irl B.
    Kirkman, M. Sue
    Klupa, Tomasz
    Ludwig, Barbara
    Norgaard, Kirsten
    Pettus, Jeremy
    Renard, Eric
    Skyler, Jay S.
    Snoek, Frank J.
    Weinstock, Ruth S.
    Peters, Anne L.
    [J]. DIABETOLOGIA, 2021, 64 (12) : 2609 - 2652
  • [20] Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
    Jin, Jian-Min
    Bai, Peng
    He, Wei
    Wu, Fei
    Liu, Xiao-Fang
    Han, De-Min
    Liu, Shi
    Yang, Jin-Kui
    [J]. FRONTIERS IN PUBLIC HEALTH, 2020, 8